The goal here is to combine the loss of p53 regulatory function in benign cells with the consequent increase in the rate of benign cell loss (via mutation into tumor cells) and the effect this mutation has on the rate of formation tumor cells in order to model solid tumor growth in the micro environment. The gene discussed is TP53; the disease is neoplasm.